Rovi remains unstoppable and leads the week on the Ibex 35; Grifols and Sacyr suffer

Foto del autor

By TP

After months of uninterrupted increases in the heat of better than expected business results and foreseeable rate cuts on both sides of the Atlantic, The Ibex 35 closed this week with slight losses of 0.72%in a consolidation movement in the vicinity of the support of 11,200 points. Although, in the short term, the declines could have some continuity, BitcoinDynamic experts highlight that Its prospects remain “very good.”

For values, The increases these days have been led by Rovi. Specifically, the pharmaceutical company's shares have risen 5.96%, expanding to 50% your profit since January. Some increases that have once again been supported by the expectations of its medicines, by the solidity of its results and by the possible sale of part of its manufacturing business for third parties.
Likewise, this week has been very propitious for CaixaBank (+4.56%), whose titles have been encouraged by the sweet moment that the financial sector is experiencing, and for Bankinter (+3.15%), another of the entities with the best graphic appearance currently.
Inditex (+2.67%) and ACS (+2.51%) and Indra (+1.86%) have also occupied the top positions in the classification. In the case of the construction company, its price has been a catalyst the entry of CriteriaCaixa into its capital with 9.4% of the shares. GRIFOLS AND SACYR LEAD THE CUTS On the declines side, the most significant have been those suffered by Grifols (-7.34%), a company that continues to be subject to high volatility.
Sacyr, with a cut of 7.14% after knowing the terms of its capital increaseand Action (-5.31%), weighed down by the reduction of forecasts for its investee Acciona Energía, have also ended up in the tail end of the national selection. Furthermore, it is worth noting Cellnex (-5.13%) and Mapfre (-4.94%), groups that have suffered a notable setback after having climbed very strongly in the previous weeks.


Weekly variations Ibex 35